Vascular Cardio-Oncology: Vascular Endothelial Growth Factor inhibitors and hypertension.
- Published in:
- Cardiovascular Research, 2019, v. 115, n. 5, p. 904, doi. 10.1093/cvr/cvz022
- By:
- Publication type:
- Article
Works matching IS 00086363 AND DT 2019 AND VI 115 AND IP 5
Results: 17
1
2
Targeted expression of cyclin D2 ameliorates late stage anthracycline cardiotoxicity.
- Published in:
- Cardiovascular Research, 2019, v. 115, n. 5, p. 960, doi. 10.1093/cvr/cvy273
- By:
- Publication type:
- Article
3
T cell checkpoint regulators in the heart.
- Published in:
- Cardiovascular Research, 2019, v. 115, n. 5, p. 869, doi. 10.1093/cvr/cvz025
- By:
- Publication type:
- Article
4
Ponatinib-induced cardiotoxicity: delineating the signalling mechanisms and potential rescue strategies.
- Published in:
- Cardiovascular Research, 2019, v. 115, n. 5, p. 966, doi. 10.1093/cvr/cvz006
- By:
- Publication type:
- Article
5
Personalized medicine in cardio-oncology: the role of induced pluripotent stem cell.
- Published in:
- Cardiovascular Research, 2019, v. 115, n. 5, p. 949, doi. 10.1093/cvr/cvz024
- By:
- Publication type:
- Article
6
Paediatric cardio-oncology: epidemiology, screening, prevention, and treatment.
- Published in:
- Cardiovascular Research, 2019, v. 115, n. 5, p. 922, doi. 10.1093/cvr/cvz031
- By:
- Publication type:
- Article
7
Microparticles from vascular endothelial growth factor pathway inhibitor-treated cancer patients mediate endothelial cell injury.
- Published in:
- Cardiovascular Research, 2019, v. 115, n. 5, p. 978, doi. 10.1093/cvr/cvz021
- By:
- Publication type:
- Article
8
Inflammation: a common contributor to cancer, aging, and cardiovascular diseases—expanding the concept of cardio-oncology.
- Published in:
- Cardiovascular Research, 2019, v. 115, n. 5, p. 824, doi. 10.1093/cvr/cvz058
- By:
- Publication type:
- Article
9
hiPSCs in cardio-oncology: deciphering the genomics.
- Published in:
- Cardiovascular Research, 2019, v. 115, n. 5, p. 935, doi. 10.1093/cvr/cvz018
- By:
- Publication type:
- Article
10
A current understanding of drug-induced QT prolongation and its implications for anticancer therapy.
- Published in:
- Cardiovascular Research, 2019, v. 115, n. 5, p. 895, doi. 10.1093/cvr/cvz013
- By:
- Publication type:
- Article
11
Corrigendum to: Cardiovascular toxicities associated with immune checkpoint inhibitors.
- Published in:
- Cardiovascular Research, 2019, v. 115, n. 5, p. 868, doi. 10.1093/cvr/cvz082
- Publication type:
- Article
12
Completing the genetic spectrum influencing coronary artery disease: from germline to somatic variation.
- Published in:
- Cardiovascular Research, 2019, v. 115, n. 5, p. 830, doi. 10.1093/cvr/cvz032
- By:
- Publication type:
- Article
13
Common risk factors for heart failure and cancer.
- Published in:
- Cardiovascular Research, 2019, v. 115, n. 5, p. 844, doi. 10.1093/cvr/cvz035
- By:
- Publication type:
- Article
14
Cardiovascular toxicities associated with immune checkpoint inhibitors.
- Published in:
- Cardiovascular Research, 2019, v. 115, n. 5, p. 854, doi. 10.1093/cvr/cvz026
- By:
- Publication type:
- Article
15
Cardioprotection in cancer therapy: novel insights with anthracyclines.
- Published in:
- Cardiovascular Research, 2019, v. 115, n. 5, p. 915, doi. 10.1093/cvr/cvz023
- By:
- Publication type:
- Article
16
Cardio-oncology: a novel platform for basic and translational cardiovascular investigation driven by clinical need.
- Published in:
- Cardiovascular Research, 2019, v. 115, n. 5, p. 819, doi. 10.1093/cvr/cvz048
- By:
- Publication type:
- Article
17
Cardiac arrhythmia considerations of hormone cancer therapies.
- Published in:
- Cardiovascular Research, 2019, v. 115, n. 5, p. 878, doi. 10.1093/cvr/cvz020
- By:
- Publication type:
- Article